As activist Starboard teams up with former Pfizer executives, the pharma giant’s lack of focus is in the spotlight.
In another blow to its $525 million buyout of ReViral, Pfizer has ended development of sisunatovir, an oral inhibitor ...
Is your company bracing for Milton or working to provide aid in anticipation of the storm? | Pfizer—which opened a global hub ...
(Reuters) - U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age ...
Since 2011, Starboard Value's Jeff Smith has extracted board seats and profits from corporate America — by force if necessary ...
Pfizer (PFE) stock may present opportunities for patient investors. Read how this biotech giant may deliver long-term ...